|
|
|
|
|
by andsoitis
438 days ago
|
|
> their patent is still owned by certain oligarchy. I don’t know that it’s helpful to have such a blunt and un-nuanced take. Theres no “certain oligarchy” that holds a single patent on "chemotherapy" as a broad concept, as it encompasses various chemical treatments for cancer. specific chemotherapy drugs and methods are patented by pharmaceutical companies and research institutions, for example: - NanOlogy LLC: holds a patent for a method involving injecting large surface area microparticle taxanes directly into the tumor, combined with systemic delivery of immunotherapeutic agents. - Johns Hopkins University: assigned patent rights for a method related to cancer treatment to Becton-Dickinson & Company, which then sublicensed them to Baxter. - University of Cincinnati Clermont College: has a patent for breakthrough chemotherapy technology involving nanocarriers. - Northeastern University: reports a patented molecule, WYC-209, that eliminates cancer cells. |
|